Which progresses faster, autoimmune hepatitis or hepatitis B?

In general, "autoimmune liver disease" refers to autoimmune hepatitis, while "hepatitis B" refers to chronic viral hepatitis B. Autoimmune hepatitis tends to progress more rapidly. The specific analysis is as follows:

Chronic viral hepatitis B is defined by a positive test for hepatitis B virus that lasts for more than six months, or by an unclear onset date but with clinical manifestations of chronic hepatitis. Autoimmune hepatitis, on the other hand, is a chronic progressive liver inflammatory disease mediated by autoimmune responses. Its clinical features include varying degrees of elevated serum aminotransferase levels, hypergammaglobulinemia, and positive autoantibodies. Histologically, it is characterized by interface hepatitis predominantly involving lymphocytic and plasma cell infiltration. Generally speaking, autoimmune hepatitis progresses faster than chronic viral hepatitis B. Severe cases of autoimmune hepatitis may rapidly advance to cirrhosis and liver failure, and the prognosis is often poor.

Additionally, although chronic viral hepatitis B progresses more slowly, its infectivity cannot be overlooked. Therefore, patients with either autoimmune hepatitis or chronic viral hepatitis B should seek timely medical evaluation and treatment at a hospital.

If a patient experiences any discomfort or symptoms, it is recommended to promptly visit a hospital for diagnosis and treatment to avoid delays in managing the condition.